Yoichiro Yoshida

2.2k total citations · 1 hit paper
94 papers, 1.7k citations indexed

About

Yoichiro Yoshida is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yoichiro Yoshida has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Yoichiro Yoshida's work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Treatment and Pharmacology (25 papers) and Chemotherapy-related skin toxicity (15 papers). Yoichiro Yoshida is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Cancer Treatment and Pharmacology (25 papers) and Chemotherapy-related skin toxicity (15 papers). Yoichiro Yoshida collaborates with scholars based in Japan and United States. Yoichiro Yoshida's co-authors include Hiroto Izumi, Kimitoshi Kohno, Takayuki Torigoe, Hiroshi Ishiguchi, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Hidetaka Uramoto, Takeshi Yoshida and Minoru Nomoto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yoichiro Yoshida

88 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

2003 543 citations Hiroto Izumi, Takayuki Torigoe et al. profile →

Peers

Countries citing papers authored by Yoichiro Yoshida

Since Specialization

Citations

This map shows the geographic impact of Yoichiro Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Yoshida more than expected).

Fields of papers citing papers by Yoichiro Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Yoshida. The network helps show where Yoichiro Yoshida may publish in the future.

Co-authorship network of co-authors of Yoichiro Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichiro Yoshida. A scholar is included among the top collaborators of Yoichiro Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichiro Yoshida. Yoichiro Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer 2024 ·Oncology Letters ·(unknown), Takashi Kamigaki, Kiichi Sugimoto, Takeshi Yamada, Yoichiro Yoshida, (unknown), (unknown), (unknown), Takuma Iwai, Akihisa Matsuda, Teppei Yamada, Suguru Hasegawa, Shigenori Goto, Rishu Takimoto, Kazuhiro Sakamoto	1
2	Current Status of Therapeutic Drug Monitoring of 5-Fluorouracil Prodrugs 2020 ·Anticancer Research ·Yasuhiro Hashimoto, Yoichiro Yoshida, Teppei Yamada, Naoya Aisu, Gumpei Yoshimatsu, Fumihiro Yoshimura, Suguru Hasegawa	18
3	Avoiding urethral and rectal injury during transperineal abdominoperineal resection in male patients with anorectal cancer 2020 ·Surgical Endoscopy ·Suguru Hasegawa, (unknown), (unknown), (unknown), Hideki Nagano, (unknown), (unknown), Naoya Aisu, Gumpei Yoshimatsu, (unknown), Yoichiro Yoshida	7
4	5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine 2020 ·Scientific Reports ·Yoichiro Yoshida, Yasuhiro Hashimoto, Makoto Miyazaki, Naoya Aisu, Teppei Yamada, (unknown), (unknown), (unknown), Hideki Nagano, Hideki Shimaoka, (unknown), (unknown), Gumpei Yoshimatsu, Fumihiro Yoshimura, Fumiaki Kiyomi, Suguru Hasegawa	3
5	Combined laparoscopic and transperineal endoscopic total pelvic exenteration for local recurrence of rectal cancer 2020 ·Techniques in Coloproctology ·Suguru Hasegawa, (unknown), (unknown), (unknown), Hideki Nagano, (unknown), Naoya Aisu, Gumpei Yoshimatsu, Yoichiro Yoshida	10
6	KRAS野生型転移性結腸直腸癌(太平洋研究)患者におけるフルオロピリミジンの有無による第2線パニツムマブおよびイリノテカンの多施設オープンラベル無作為化第II相試験【JST・京大機械翻訳】 2019 ·Medical Oncology ·(unknown), Hiromichi Maeda, Keiichiro Ishibashi, Keiji Hirata, (unknown), (unknown), Hiroyoshi Takemoto, Mitsunobu Imasato, Yoichiro Yoshida, Yoshinori Munemoto, (unknown), (unknown), Yoshihiro Hotta, (unknown), Takeshi Nagasaka, Satoshi Morita, (unknown), Hideyuki Mishima	1
7	Transperineal abdominoperineal resection synchronously assisted by laparoscopic approach for low rectal cancer directly invading the posterior wall of the vagina 2019 ·Techniques in Coloproctology ·Daibo Kojima, Suguru Hasegawa, (unknown), (unknown), (unknown), (unknown), Yoichiro Yoshida	3
8	Phase 2 study of perioperative chemotherapy with SOX and surgery for stage III colorectal cancer (SOS3 study) 2019 ·Scientific Reports ·Naoya Aisu, Yoichiro Yoshida, (unknown), (unknown), Daibo Kojima, Suguru Hasegawa	2
9	Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer 2018 ·Anticancer Research ·Yoichiro Yoshida, (unknown), (unknown), (unknown), (unknown), (unknown), Naoya Aisu, Daibo Kojima, (unknown), Suguru Hasegawa	12
10	Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated αβ T-cells 2017 ·Anticancer Research ·(unknown), Yoichiro Yoshida, Yasushi Yamauchi, Naoya Aisu, Daibo Kojima, Toshiyuki Mera, Daisuke Kato, Toshihiro Tanaka, (unknown), Kosei Yasumoto, Takashi Kamigaki, Shigenori Goto, Yoshihiro Hamada, Satoshi Nimura, Shohta Kodama, Suguru Hasegawa	4
11	Difference in Neutropenia due to Administration Schedule of TAS-102 2017 ·Case Reports in Oncology ·Yoichiro Yoshida, Naoya Aisu, (unknown), (unknown), (unknown), Daibo Kojima, Toshiyuki Mera, Suguru Hasegawa	4
12	Adoptive Chemoimmunotherapy Using Activated αβ T Cells for Stage IV Colorectal Cancer. 2016 ·PubMed ·Yoichiro Yoshida, (unknown), Teppei Yamada, Naoya Aisu, Daibo Kojima, Toshiyuki Mera, Toshihiro Tanaka, (unknown), Kosei Yasumoto, Takashi Kamigaki, Shigenori Goto, Yuichi Yamashita, Suguru Hasegawa	10
13	Clinical study on medical value of adoptive immunotherapy with chemotherapy for stage IV colorectal cancer (COMVI study). 2016 ·Journal of Clinical Oncology ·Yoichiro Yoshida, (unknown), Teppei Yamada, Naoya Aisu, Daibo Kojima, Toshiyuki Mera, (unknown), Toshihiro Tanaka, (unknown), Kosei Yasumoto, Takashi Kamigaki, Shigenori Goto, Yuichi Yamashita	2
14	Potential of the 5-fluorouracil dose-escalation method for dihydropyrimidine dehydrogenase-deficient patients 2015 ·Annals of Oncology ·Yoichiro Yoshida, Kenichiro Ogura, Akira Hiratsuka, Naoya Aisu, (unknown), Daibo Kojima, (unknown), Kentaro Ogata, (unknown), Yuichi Yamashita	2
15	A Report of Disseminated Carcinomatosis of the Bone Marrow Originating from Transverse Colon Cancer Successfully Treated with Chemotherapy Using XELOX plus Bevacizumab 2014 ·Case Reports in Oncology ·(unknown), Yoichiro Yoshida, Naoya Aisu, (unknown), Seiichiro Hoshino, Toshihiro Tanaka, Satoshi Nimura, Kazuo Tamura, Yuichi Yamashita	14
16	Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX 2010 ·Cancer Science ·Yoichiro Yoshida, Junichi Hasegawa, Riichiro Nezu, (unknown), Masaki Hirota, Kiyoshi Kawano, Hiroto Izumi, Kimitoshi Kohno	27
17	Cisplatin Resistance and Transcription Factors 2005 ·PubMed ·Takayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, Yoichiro Yoshida, Mizuho Tanabe, Takeshi Yoshida, Tomonori Igarashi, (unknown), Tetsuro Wakasugi, (unknown), Yasutomo Momii, Michihiko Kuwano, Kimitoshi Kohno	112
18	ZNF143 activates gene expression in response to DNA damage and binds to cisplatin‐modified DNA 2004 ·International Journal of Cancer ·Hiroshi Ishiguchi, Hiroto Izumi, Takayuki Torigoe, Yoichiro Yoshida, Hiroshi Kubota, Sadatoshi Tsuji, Kimitoshi Kohno	33
19	Binding of RNA to p53 regulates its oligomerization and DNA-binding activity 2004 ·Oncogene ·Yoichiro Yoshida, Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Takeshi Yoshida, Hideaki Itoh, Kimitoshi Kohno	35
20	Determination of the secondary structure in solution of the Escherichia coli DnaA DNA-binding domain 2002 ·Biochemical and Biophysical Research Communications ·Takayuki Obita, (unknown), Masayuki Su’etsugu, Yoichiro Yoshida, (unknown), Tsutomu Katayama, Tadashi Ueda, Taiji Imoto	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact